Document text
Principal Investigator: BENJAMIN JOACHIM SCHMIEDEL
Organization: LA JOLLA INSTITUTE FOR IMMUNOLOGY
Fiscal Year: 2024
Award: $274,500
Funding agency: National Institute of Allergy and Infectious Diseases
PROJECT SUMMARY/ABSTRACT
The clinical presentation of SARS-CoV-2 infection in humans can range from very mild or no symptoms to severe
respiratory failure. Although hyperactivation of various cellular components of the immune system have been
observed in patients with severe COVID-19 illness, the host genetic factors that determine susceptibility to
severe COVID-19 illness are not well understood. GWAS studies have reported several genetic loci that are
significantly associated with severe COVID-19 and defined several target genes based on their proximity to the
risk loci, although this approach does not accurately prioritize causal genes. We conducted one of the first
transcriptome-wide association study (TWAS) in primary immune cells to define genes that are associated with
COVID-19 severity. In this R21 proposal, we will focus on defining functional COVID-19 risk variants linked to
top two candidate genes (OAS1 and IL10RB) from our genetic analyses.
In Aim 1, we will determine the functional COVID-19 risk eQTLs associated with OAS1 expression in non-
classical monocytes (NCM). Our TWAS study showed significant association of COVID-19 severity with reduced
expression of interferon-inducible gene (OAS1) specifically in NCM. OAS1 encodes for oligoadenylate synthase
family of proteins that degrade viral RNA and activate anti-viral responses, thus variants altering its expression
levels, especially in NCM, a cell type which has been implicated in COVID-19 pathogenesis, are likely to have
an important role in host immune responses. Here, we will undertake experimental studies to define the functional
variant(s) in the dense OAS1 Neanderthal haploblock harboring >100 SNPs. Briefly, we will perform (i) CRISPRi
assays to determine functional enhancers that overlap COVID-19 risk SNPs, (ii) luciferase reporter assays to
determine the function variants in such enhancers, (iii) ChIP to determine allele-specific binding of the
transcription factor RXRα the binding of which is predicted to be disrupted by COVID-19-risk variants, and (iv)
HDR-mediated editing of prioritized COVID-19-risk eQTLs to definitively establish functionality.
In Aim 2, we will determine the function COVID-19 risk eQTLs associated with IL10RB expression in NK cells
and T cells. Our TWAS showed that increased expression of IL10RB in NK cells was significantly associated
with COVID-19 severity. IL10RB encodes for IL-10 receptor beta, and given the immunomodulatory role of IL-
10, it is likely that the higher expression on the IL10RB in NK cells and T cells may enhance their responsiveness
to IL-10. Here, we will perform experimental studies as described in Aim 1 to define the functional COVID-19-
risk variants that are predicted to perturb the binding of the transcription factors TCF12 and GATA-3 and their
role in the modulation of IL10RB expression in NK cells in T cells.
Overall, functional studies in this R21 program will provide important mechanistic insights into the genetic basis
of COVID-19 severity.
Terms: <Affect><Airway failure><Alleles><Allelomorphs><Anti-viral Response><Assay><Automobile Driving><Basal Transcription Factor><Basal transcription factor genes><Binding><Bioassay><Biological Assay><Blood monocyte><COVID disease severity><COVID severity><COVID-19><COVID-19 affected><COVID-19 consequence><COVID-19 disease severity><COVID-19 effect><COVID-19 impact><COVID-19 impacted><COVID-19 infection><COVID-19 pathogenesis><COVID-19 predisposition><COVID-19 related risk><COVID-19 risk><COVID-19 risk factor><COVID-19 severity><COVID-19 susceptibility><COVID-19 virus infection><COVID-19 vulnerability><COVID19 disease severity><COVID19 infection><COVID19 pathogenesis><COVID19 severity><CRF2-4><CRFB4><CRISPR interference><CRISPR-dCas9-mediated repression><CRISPR/dCas9 interference><CRISPR/dCas9-mediated transcriptional inhibition><CRISPRi><CSIF><CSIF-10><CV-19><Candidate Disease Gene><Candidate Gene><Cell Body><Cells><Clinical><Clustered Regularly Interspaced Short Palindromic Repeats interference><Code><Coding System><Coronavirus Infectious Disease 2019><Coronavirus disease 2019 predisposition><Coronavirus disease 2019 susceptibility><Coronavirus disease 2019 vulnerability><Cytokine Synthesis Inhibitory Factor><Cytotoxic cell><DNA Sequence><Data Bases><Data Set><Databases><Defect><Disease><Disorder><Economics><Enhancers><Ethnic Origin><Ethnicity><Exploratory/Developmental Grant><Expression Signature><Functional RNA><Future><GWA study><GWAS><Gene Expression><Gene Expression Profile><General Transcription Factor Gene><General Transcription Factors><Genes><Genetic><Genetic Determinism><Genetic Markers><Genetic Polymorphism><Genetic Risk><Genetic analyses><Hereditary><Hospital Admission><Hospitalization><Human><IFN><IL-10><IL-10 receptor><IL-10R2><IL10><IL10A><IL10RB><IL10RB gene><Immune><Immune response><Immune system><Immunes><Immunological response><Immunomodulation><Impairment><Individual><Inherited><Interferons><Interleukin 10 Precursor><Interleukin-10><K lymphocyte><Link><Long COVID><Long COVID-19><Long coronavirus disease><Long coronavirus disease 2019><Luciferase Immunologic><Luciferases><Maps><Marrow monocyte><Mediating><Meta-Analysis><Modeling><Modern Man><Molecular><Molecular Interaction><Morbidity><Morbidity - disease rate><NK Cells><Natural Killer Cells><Non-Coding><Non-Coding RNA><Non-translated RNA><Noncoding RNA><Nontranslated RNA><Pathogenesis><Pathway interactions><Patients><Population><Predisposed to COVID-19><Predisposed to SARS-CoV-2><Predisposed to Severe acute respiratory syndrome coronavirus 2><Predisposition><Protein Family><QTL><Quantitative Trait Loci><R21 Mechanism><R21 Program><Reporter><Reporting><Respiratory Failure><Risk><Risk-associated variant><Role><SARS-CoV-2 disease severity><SARS-CoV-2 infection><SARS-CoV-2 predisposition><SARS-CoV-2 severity><SARS-CoV-2 susceptibility><SARS-CoV-2 vulnerability><SARS-CoV2 infection><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 predisposition><Severe acute respiratory syndrome coronavirus 2 susceptibility><Severe acute respiratory syndrome coronavirus 2 vulnerability><Severities><Severity of illness><Susceptibility><Symptoms><T-Cells><T-Lymphocyte><Testing><Transcription Factor Proto-Oncogene><Transcription factor genes><Untranslated RNA><Vaccines><Validation><Variant><Variation><Work><acute infection><breakthrough infection><causal allele><causal gene><causal mutation><causal variant><causative mutation><causative variant><cell type><chronic COVID><chronic COVID-19><chronic novel coronavirus disease 2019><coronavirus disease 2019><coronavirus disease 2019 consequence><coronavirus disease 2019 disease severity><coronavirus disease 2019 effect><coronavirus disease 2019 impact><coronavirus disease 2019 infection><coronavirus disease 2019 pathogenesis><coronavirus disease 2019 risk><coronavirus disease 2019 risk factor><coronavirus disease 2019 severity><coronavirus disease severity><coronavirus disease-19><coronavirus disease-19 impact><coronavirus disease-19 pathogenesis><coronavirus infectious disease-19><data base><disease risk><disease severity><disorder risk><driving><economic><epigenomics><exome sequencing><exome-seq><experiment><experimental research><experimental study><experiments><exploratory developmental study><gene biomarker><gene expression biomarker><gene expression pattern><gene expression signature><gene locus><gene marker><gene signature biomarker><genetic analysis><genetic biomarker><genetic determinant><genetic locus><genome scale><genome wide association><genome wide association scan><genome wide association studies><genome wide association study><genome-wide><genomewide><genomewide association scan><genomewide association studies><genomewide association study><genomic location><genomic locus><global gene expression><global transcription profile><host response><immune modulation><immune regulation><immune system response><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><in vivo><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><insight><interleukin-10 receptor><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><long haul COVID><long haul COVID-19><long haul coronavirus disease><long haul coronavirus disease 2019><long-hauler COVID><long-hauler COVID-19><long-hauler coronavirus disease 2019><long-hauler syndrome><long-term COVID><long-term COVID-19><long-term coronavirus disease><long-term coronavirus disease 2019><longterm COVID><longterm COVID-19><longterm coronavirus disease><longterm coronavirus disease 2019><model building><monocyte><mortality><noncoding><novel><oligoadenylate><pandemic><pandemic disease><pathway><persistent COVID-19><polymorphism><post COVID syndrome><post COVID-19 syndrome><post acute COVID syndrome><post acute COVID-19><post acute COVID-19 syndrome><post acute SARS-CoV-2><post acute coronavirus disease 2019><post acute coronavirus disease 2019 syndrome><post acute coronavirus disease syndrome><post acute severe acute respiratory syndrome coronavirus 2><post coronavirus disease 2019 syndrome><post coronavirus disease syndrome><post-acute phases of COVID-19><predisposed to Coronavirus disease 2019><prolonged COVID-19 symptoms><promoter><promotor><repressing CRISPR-dCas9 system><response><risk allele><risk associated with COVID-19><risk factor associated with COVID-19><risk factor related to COVID-19><risk gene><risk genotype><risk loci><risk locus><risk related to COVID-19><risk variant><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 disease severity><severe acute respiratory syndrome coronavirus 2 severity><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><social role><susceptible to COVID-19><susceptible to Coronavirus disease 2019><susceptible to SARS-CoV-2><susceptible to Severe acute respiratory syndrome coronavirus 2><thymus derived lymphocyte><transcription factor><transcriptional profile><transcriptional signature><transcriptome><validations><viral RNA><virus RNA><vulnerable to COVID-19><vulnerable to Coronavirus disease 2019><vulnerable to SARS-CoV-2><vulnerable to Severe acute respiratory syndrome coronavirus 2><whole genome association analysis><whole genome association studies><whole genome association study>